BioAtla, Inc. SEC filings BCAB
BioAtla, Inc. has 509 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (material agreement, agreement ended, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale
|
Oct 20, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 28, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 16, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Other events
|
Apr 2, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 23, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
|
Mar 2, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Other events
|
Feb 9, 2026 | Feb 8, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
Jan 30, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jan 12, 2026 | Jan 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 31, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 30, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 21, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Other events
|
Sep 22, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Listing notice
|
May 16, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 7, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 20, 2024 | Dec 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
May 17, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 24, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Other events
|
Feb 12, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 8, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 13, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Other events
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 7, 2022 | Nov 4, 2022 |
| 8-K |
Current report
Other events
|
Nov 4, 2022 | Nov 4, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2022 | Jun 3, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 11, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2022 | Feb 21, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 11, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 21, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Agreement ended
|
Nov 19, 2021 | Nov 18, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 29, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2021 | Feb 3, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 18, 2020 | Dec 18, 2020 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCAB (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1826892
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.